TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation S Jouan-Lanhouet, MI Arshad, C Piquet-Pellorce, C Martin-Chouly, ... Cell Death & Differentiation 19 (12), 2003-2014, 2012 | 385 | 2012 |
Role of matrix metalloproteinases in the development of airway inflammation and remodeling V Lagente, B Manoury, S Nenan, C Le Quement, C Martin-Chouly, ... Brazilian journal of medical and biological research 38, 1521-1530, 2005 | 244 | 2005 |
Obesity II: Establishing causal links between chemical exposures and obesity JJ Heindel, S Howard, K Agay-Shay, JP Arrebola, K Audouze, PJ Babin, ... Biochemical pharmacology 199, 115015, 2022 | 102 | 2022 |
Impaired functions of macrophage from cystic fibrosis patients: CD11b, TLR-5 decrease and sCD14, inflammatory cytokines increase K Simonin-Le Jeune, A Le Jeune, S Jouneau, C Belleguic, PF Roux, ... PloS one 8 (9), e75667, 2013 | 94 | 2013 |
The impact of impaired macrophage functions in cystic fibrosis disease progression M Lévêque, S Le Trionnaire, P Del Porto, C Martin-Chouly Journal of Cystic Fibrosis 16 (4), 443-453, 2017 | 81 | 2017 |
Phagocytosis depends on TRPV2-mediated calcium influx and requires TRPV2 in lipids rafts: alteration in macrophages from patients with cystic fibrosis M Lévêque, A Penna, S Le Trionnaire, C Belleguic, B Desrues, ... Scientific Reports 8 (1), 4310, 2018 | 73 | 2018 |
Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors CAE Martin-Chouly, A Astier, C Jacob, MP Pruniaux, C Bertrand, ... Life sciences 75 (7), 823-840, 2004 | 67 | 2004 |
Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes C Martin-Chouly, C Morzadec, M Bonvalet, MD Galibert, O Fardel, ... Molecular immunology 48 (6-7), 956-965, 2011 | 61 | 2011 |
Global effects of inorganic arsenic on gene expression profile in human macrophages E Bourdonnay, C Morzadec, L Sparfel, MD Galibert, S Jouneau, ... Molecular immunology 46 (4), 649-656, 2009 | 58 | 2009 |
Selective PDE4 inhibitors as potent anti-inflammatory drugs for the treatment of airway diseases V Lagente, C Martin-Chouly, E Boichot, MA Martins, PMR Silva Memórias do Instituto Oswaldo Cruz 100, 131-136, 2005 | 53 | 2005 |
Influence of (±)-CP-96,345 and SR 48968 on electrical field stimulation of the isolated guinea-pig main bronchus CAE Martin, E Naline, X Emonds-Alt, C Advenier European journal of pharmacology 224 (2-3), 137-143, 1992 | 53 | 1992 |
The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-α production in whole blood from COPD patients M Ouagued, CAE Martin-Chouly, G Brinchault, C Leportier-Comoy, ... Pulmonary pharmacology & therapeutics 18 (1), 49-54, 2005 | 47 | 2005 |
Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in pulmonary fibrosis S Guillot, P Delaval, G Brinchault, S Caulet-Maugendre, A Depince, ... Experimental lung research 32 (3-4), 81-97, 2006 | 46 | 2006 |
Soluble CD14 acts as a DAMP in human macrophages: origin and involvement in inflammatory cytokine/chemokine production M Leveque, K Simonin-Le Jeune, S Jouneau, S Moulis, B Desrues, ... FASEB Journal 31 (5), 1891-1902, 2017 | 44 | 2017 |
Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen ML De Temmerman, J Rejman, RE Vandenbroucke, S De Koker, C Libert, ... Journal of controlled release 158 (2), 233-239, 2012 | 44 | 2012 |
Anti-inflammatory effect of fluvastatin on IL-8 production induced by Pseudomonas aeruginosa and Aspergillus fumigatus antigens in cystic fibrosis S Jouneau, M Bonizec, C Belleguic, B Desrues, G Brinchault, J Galaine, ... PLoS One 6 (8), e22655, 2011 | 42 | 2011 |
Modulation of endothelial permeability by 1‐O‐alkylglycerols K Marigny, F Pedrono, CAE Martin‐Chouly, H Youmine, B Saiag, ... Acta physiologica scandinavica 176 (4), 263-268, 2002 | 40 | 2002 |
In vitro effects of HOE 140 in human bronchial and vascular tissue M Félétou, CAE Martin, M Molimard, E Naline, M Germain, C Thurieau, ... European journal of pharmacology 274 (1-3), 57-64, 1995 | 39 | 1995 |
MiR-146a is over-expressed and controls IL-6 production in cystic fibrosis macrophages FR Luly, M Lévêque, V Licursi, G Cimino, C Martin-Chouly, N Théret, ... Scientific Reports 9 (1), 16259, 2019 | 36 | 2019 |
Role of PDE4 in superoxide anion generation through p44/42MAPK regulation: a cAMP and a PKA‐independent mechanism C Jacob, C Szilagyi, JM Allen, C Bertrand, V Lagente British journal of pharmacology 143 (2), 257-268, 2004 | 33 | 2004 |